APIMEDS PHARMACEUTICALS US, INC. Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage of 40.00% as of 2023-09-21, per its 10-Q filed 2025-05-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage · last filed 2025-05-20
- 2023-09-21: Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 40.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage |
|---|---|
| 2023-09-21 | 40.00% 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |